Cardiovascular disorder
Not yet recruitingRosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care
Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care
- Disease:Cardiovascular disorder
- Substances:Rosuvastatin Zinc
Denmark- Participants:18–64 years · 65+ years
- Substances:Rosuvastatin Zinc
- Sponsor:Copenhagen University Hospital





